<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0019246"><a href="http://purl.obolibrary.org/obo/MONDO_0019246">MONDO:0019246</a></h3>
<p><strong>Label:</strong> disorder of lysosomal amino acid transport</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0009065">MONDO:0009065</a> (cystinosis, nephropathic), <a href="http://purl.obolibrary.org/obo/MONDO_0019366">MONDO:0019366</a> (Free sialic acid storage disease), <a href="http://purl.obolibrary.org/obo/MONDO_0016239">MONDO:0016239</a> (cystinosis), <a href="http://purl.obolibrary.org/obo/MONDO_0010028">MONDO:0010028</a> (sialuria),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_604369">OMIM:604369</a>, <a href="http://purl.obolibrary.org/obo/OMIM_219750">OMIM:219750</a>, <a href="http://purl.obolibrary.org/obo/OMIM_219900">OMIM:219900</a>, <a href="http://purl.obolibrary.org/obo/OMIM_219800">OMIM:219800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_834">Orphanet:834</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3166">Orphanet:3166</a>, <a href="http://www.orpha.net/ORDO/Orphanet_411629">Orphanet:411629</a>, <a href="http://purl.obolibrary.org/obo/OMIM_269921">OMIM:269921</a>, <a href="http://www.orpha.net/ORDO/Orphanet_213">Orphanet:213</a>, <a href="http://purl.obolibrary.org/obo/OMIM_269920">OMIM:269920</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000531">HP:0000531</a> (Corneal crystals) 70.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0002748">HP:0002748</a> (Rickets) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification) and <a href="http://purl.obolibrary.org/obo/HP_0012072">HP:0012072</a> (Aciduria) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0011446">HP:0011446</a> (Abnormality of higher mental function) and <a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0011014">HP:0011014</a> (Abnormal glucose homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0011013">HP:0011013</a> (Abnormality of carbohydrate metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0007957">HP:0007957</a> (Corneal opacity) and <a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0004354">HP:0004354</a> (Abnormality of carboxylic acid metabolism) and <a href="http://purl.obolibrary.org/obo/HP_0011849">HP:0011849</a> (Abnormal bone ossification) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0012072">HP:0012072</a> (Aciduria) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0011446">HP:0011446</a> (Abnormality of higher mental function) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0011014">HP:0011014</a> (Abnormal glucose homeostasis) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0011013">HP:0011013</a> (Abnormality of carbohydrate metabolism/homeostasis) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001959">HP:0001959</a> (Polydipsia) and <a href="http://purl.obolibrary.org/obo/HP_0004349">HP:0004349</a> (Reduced bone mineral density) and <a href="http://purl.obolibrary.org/obo/HP_0007957">HP:0007957</a> (Corneal opacity) 65.00%</li>
</ul>
</body>
</html>
